LUNG
LUNG
NASDAQ · Health Care

Pulmonx Corp

$1.31
+0.13 (+11.02%)
As of Mar 31, 3:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
96.28M
Net Income
-57,451,386
Gross Margin
74.2%
Profit Margin
-59.7%
Rev Growth
+19.0%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 96.28M 80.89M 18.36M 19.89M
Gross Profit 71.43M 60.01M 11.85M 12.83M
Operating Income -57,092,553 -43,168,358 2.61M 3.02M
Net Income -57,451,386 -43,439,676 2.39M 2.44M
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Rev Growth +19.0% +19.0% -0.5% +20.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.65M 10.65M 22.81M 25.99M
Total Equity 15.54M 15.54M 28.06M 25.55M
D/E Ratio 0.69 0.69 0.81 1.02
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -55,871,505 -44,592,060 3.71M 4.15M
Free Cash Flow 1.86M 2.73M